FibroGen FGEN Stock
FibroGen Price Chart
FibroGen FGEN Financial and Trading Overview
| FibroGen stock price | 9.71 USD |
| Previous Close | 9.02 USD |
| Open | 9.23 USD |
| Bid | 6.83 USD x 200 |
| Ask | 11.37 USD x 200 |
| Day's Range | 9.23 - 9.75 USD |
| 52 Week Range | 4.85 - 21.94 USD |
| Volume | 31.12K USD |
| Avg. Volume | 32.67K USD |
| Market Cap | 39.28M USD |
| Beta (5Y Monthly) | 0.773 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 43 USD |
FGEN Valuation Measures
| Enterprise Value | -24709730 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.81255233 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.7338243 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | -2.978 |
| Enterprise Value/EBITDA | 0.426 |
Trading Information
FibroGen Stock Price History
| Beta (5Y Monthly) | 0.773 |
| 52-Week Change | -31.031% |
| S&P500 52-Week Change | 22.71% |
| 52 Week High | 21.94 USD |
| 52 Week Low | 4.85 USD |
| 50-Day Moving Average | 8.82 USD |
| 200-Day Moving Average | 8.92 USD |
FGEN Share Statistics
| Avg. Volume (3 month) | 32.67K USD |
| Avg. Daily Volume (10-Days) | 20.85K USD |
| Shares Outstanding | 4.05M |
| Float | 3.58M |
| Short Ratio | 3.2 |
| % Held by Insiders | 1.65% |
| % Held by Institutions | 28.01% |
| Shares Short | 131.35K |
| Short % of Float | 3.30% |
| Short % of Shares Outstanding | 3.25% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 2598.86% |
| Operating Margin (ttm) | -499.071% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.42% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 8.3M USD |
| Revenue Per Share (ttm) | 2.05 USD |
| Quarterly Revenue Growth (yoy) | 774.80% |
| Gross Profit (ttm) | -30351000 USD |
| EBITDA | -58064000 USD |
| Net Income Avi to Common (ttm) | -52259000 USD |
| Diluted EPS (ttm) | -12.85 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 117.98M USD |
| Total Cash Per Share (mrq) | 29.16 USD |
| Total Debt (mrq) | 19.47M USD |
| Total Debt/Equity (mrq) | 111.36 USD |
| Current Ratio (mrq) | 3.709 |
| Book Value Per Share (mrq) | -4.209 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16912000 USD |
| Levered Free Cash Flow (ttm) | -91708000 USD |
Profile of FibroGen
| Country | United States |
| State | CA |
| City | San Francisco |
| Address | 350 Bay Street |
| ZIP | 94133 |
| Phone | 415 978 1200 |
| Website | https://www.fibrogen.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 225 |
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Roxadustat, a small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. Its pipeline products include FG-3165 and FG-3175, an anti-GAL-9 antibody for treatment of solid tumors. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.
Q&A For FibroGen Stock
What is a current FGEN stock price?
FibroGen FGEN stock price today per share is 9.71 USD.
How to purchase FibroGen stock?
You can buy FGEN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for FibroGen?
The stock symbol or ticker of FibroGen is FGEN.
Which industry does the FibroGen company belong to?
The FibroGen industry is Biotechnology.
How many shares does FibroGen have in circulation?
The max supply of FibroGen shares is 4.05M.
What is FibroGen Price to Earnings Ratio (PE Ratio)?
FibroGen PE Ratio is 0.00000000 now.
What was FibroGen earnings per share over the trailing 12 months (TTM)?
FibroGen EPS is 0 USD over the trailing 12 months.
Which sector does the FibroGen company belong to?
The FibroGen sector is Healthcare.
FibroGen FGEN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3090.39 USD — |
-0.26
|
— — | 3063.94 USD — | 3108.39 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12546.99 USD — |
-2.24
|
— — | 12513.27 USD — | 12692.24 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31560.2 USD — |
-2.21
|
— — | 31469.2 USD — | 31924.72 USD — | — - | — — |
|
US Tech Philippines Utilities Lg
NQPH7000LMPHPT
US
|
1112.33 PHP 20 USD |
<0.01
|
— — | 1112.33 PHP 20 USD | 1112.33 PHP 20 USD | — - | — — |
|
US Tech AlphaDEX Multi Cap Growt
NQDXUSMLTCG
US
|
4123.39 USD — |
-2.34
|
— — | 4089.8 USD — | 4163.55 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6185.56 USD — |
+0.85
|
— — | 6121.03 USD — | 6233.73 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
6750.7 USD — |
+0.85
|
— — | 6680.28 USD — | 6803.27 USD — | — - | — — |
- {{ link.label }} {{link}}